Protein kinase B/AKT is critically involved in murine placental development and migration of human placental trophoblasts into maternal uterine tissue. However, localization of the three AKT isoforms within human placenta and their roles in extravillous trophoblasts have not been elucidated. Therefore, we analyzed the expression pattern and function of AKT1, AKT2, and AKT3 in migratory human trophoblasts using SGHPL-5 cell pools stably expressing small-hairpin microRNA (shRNAmir) against AKT1, AKT2, or AKT3 as a model. Western blot analyses using isoformspecific antibodies revealed ubiquitous expression of AKT1, AKT2, and AKT3 in primary villous and extravillous trophoblasts and the trophoblastic cell lines JEG-3, HTR-8/SVneo, and SGHPL-5. Immunofluorescence of first-trimester placentae localized AKT2 and AKT3 to the cytoplasm and nucleus, respectively, in all subtypes of cytotrophoblasts, whereas AKT1 was detected in both cellular compartments. A similar distribution of AKT isoforms was detectable in SGHPL-5 cells. Gene silencing using shRNAmir decreased protein expression of AKT1, AKT2, and AKT3 to 16%, 8%, and 11%, respectively, in SGHPL-5 cells. Compared with shRNAmir controls, proliferation and camptothecin-induced apoptosis were not affected in the different AKT knockdown cells. However, basal and epidermal growth factor (EGF)-induced trophoblast migration was significantly reduced in AKT1 and AKT3 gene-silenced cells, whereas downregulation of AKT2 was not effective. Accordingly, a decrease in EGF-stimulated phosphorylation of AKT (Ser473 and Thr308) and its downstream target mTORC1 (Ser2448) was noticed in AKT1 and AKT3 shRNAmir cell pools. In summary, the results suggest that the AKT isoforms 1 and 3 promote basal as well as EGF-induced trophoblast migration.
INTRODUCTION
Proper development of the human placenta is critical for fetal well-being and pregnancy outcome. In particular, the human placenta comprises distinct, differentiated trophoblast cell types fulfilling diverse tasks during pregnancy. Whereas the syncytium covering the surface of floating villi controls placental transport and produces pregnancy hormones, extravillous trophoblasts (EVTs) develop from anchoring villi attaching to the uterine epithelium [1] . Within anchoring villi progenitors of the proliferative cell column give rise to differentiated, invasive EVTs migrating into the underlying stroma and maternal spiral arteries. Transformation of the latter into dilated vessels is orchestrated by interstitial and endovascular trophoblasts as well as uterine cell types, such as uterine natural killer (uNK) cells involving smooth muscle cell apoptosis and elastolysis [2, 3] . This remodeling process ensures a continuous supply of nutrients and oxygen to the growing fetus. Moreover, interstitial trophoblasts produce hormones, chemokines, and angiogenic factors, eventually promoting uNK cell proliferation and angiogenesis within the placental bed [4, 5] . Failure in spiral artery remodeling, characterized by the absence of endovascular trophoblasts, was shown to be associated with pregnancy diseases such as preeclampsia and severe forms of intrauterine growth restriction [6] [7] [8] . Hence, a better understanding of the molecular mechanisms controlling EVT differentiation, invasion, and interaction with maternal uterine cell types might help to unravel the pathogenesis of gestational diseases.
In contrast to cancer cell invasion, invasion and migration of trophoblasts are precisely controlled in a time-and distancedependent manner involving balanced expression of proteases and their inhibitors, such as matrix metalloproteinases (MMPs)/tissue inhibitors of metalloproteinases (TIMPs) and urokinase plasminogen activator (uPA)/plasminogen activator inhibitors (PAIs), as well as changes in integrin-mediated adhesion [9] [10] [11] . Numerous growth factors secreted from EVTs and/or decidual cell types were shown to control trophoblast invasion and its protease systems through autocrine and/or paracrine mechanisms [12] . Signaling of these factors occurs through pathways modulating motility in other cellular systems, for example, extracellular regulated kinase (ERK), focal adhesion kinase (FAK), and Rho-associated kinase (ROCK) signaling [13] .
Along those lines, phosphatidylinositide 3-kinase (PI3K)-AKT signaling also plays a pivotal role in placental development, differentiation, and trophoblast migration. In mice, homozygous deletion of AKT affects placental development due to decreased numbers of proliferative trophoblasts [14] . Also, the PI3K-AKT pathway was shown to be involved in the differentiation of murine giant cells [15] . In humans, accumulating evidence suggests that activation of AKT positively influences migration of different, invasive trophoblast cell models. Abundant growth factors at the fetal-maternal interface (i.e., epidermal growth factor [EGF] and insulin-like growth factor II [IGF-II]) were shown to activate PI3K-AKT and AKT-dependent migration of trophoblastic HTR-8/SVneo cells [16, 17] . Similarly, activation of PI3K with specific peptides resulted in increased motility of trophoblastic SGHPL-4 cells, whereas inhibition of PI3K reduced basal and hepatocyte growth factor (HGF)-induced migration [18] . Moreover, human chorionic gonadotropin and a recombinant Wingless (Wnt) ligand were shown to increase MMP-2 secretion and migration of SGHPL-5 cells and EVTs in villous explant cultures involving AKT activation [19, 20] . PI3K-AKT signaling is also required for EGF-dependent expression of MMP-2, MMP-3, and MMP-9 in trophoblasts [19, 21] .
However, AKT is not a single enzyme. Three different isoforms-AKT1/PKBa, Akt2/PKBb, and Akt3/PKBc-were described which exhibit more than 80% protein sequence homology and play redundant as well as distinct roles in cells and tissues [22] . With respect to cell migration, dominantpositive AKT isoforms generally promote invasiveness, but AKT1 was also shown to inhibit motility in some cancer cell models [23] . Moreover, depending on the cell type, AKT1 and AKT2 may also have opposing roles in epithelial-mesenchymal transition and cell migration [24, 25] .
To gain insights into the role of AKT isoforms in trophoblasts, in the present study we investigated migration, proliferation, apoptosis, and signaling of SGHPL-5 cells stably expressing small-hairpin microRNA (shRNAmir) against AKT1, AKT2, or AKT3. Analyses of these gene-silenced cell pools suggest that the AKT isoforms 1 and 3 play critical roles in EGF-mediated SGHPL-5 trophoblast cell migration involving the downstream effector mTORC1.
MATERIALS AND METHODS

Cultivation of Trophoblast Cell Lines
SGHPL-5 cells exhibiting features of invasive trophoblasts cells, such as HLA-G and cytokeratin 7 expression, were cultivated in Dulbecco modified Eagle medium (DMEM)/Ham F-12 (PAA Laboratories GmbH) supplemented with 10% (v/v) fetal calf serum (FCS; Biochrom AG) and 0.05 mg/ml gentamicin (Invitrogen Gibco, Life Technologies) as described previously [26, 27] . HTR-8/SVneo cells were grown in RPMI 1640 (GibcoBRL, Life Technologies) supplemented with 5% (v/v) fetal bovine serum (Biochrom), 100 U/ml penicillin, 100 lg/ml streptomycin (GibcoBRL), and 2 mM glutamine (GibcoBRL) as mentioned previously [28] . The choriocarcinoma cell line JEG-3 was cultivated in DMEM (GibcoBRL) supplemented with 10% (v/v) fetal bovine serum (Biochrom) and 0.05 mg/ml gentamicin (Invitrogen Gibco, Life Technologies) as previously described [29] .
Collection of Placental Tissues
Placental tissues of early pregnancy (n ¼ 28) between the 7th and 12th wk of gestation were obtained from legal abortions of uncomplicated pregnancies. Use of tissues was approved by the ethics committee of the Medical University of Vienna.
Immunofluorescence of First-Trimester Placenta and SGHPL-5 Cells
First-trimester placental tissues were embedded in paraffin and sectioned on a microtome as described previously [30] . Briefly, after fixation in 4% (w/v) paraformaldehyde for 24 h at 48C, samples were dehydrated and embedded in paraffin (Merck). Serial sections were prepared (5 lm), deparaffinized, and heated in the microwave (2 3 5 min, 850 W). Blocking, antibody staining, and sample analysis using immunofluorescence were performed as previously reported [26] . The following antibodies were used: Akt1 (rabbit; 1:100; Epitomics); Akt2 (rabbit; 2 lg/ml; Santa Cruz Biotechnology Inc.); Akt3 (rabbit; 1.8 lg/ml; Sigma Life Science); cytokeratin 7 (mouse; 8.3 lg/ml clone OV-TL 12/30; Dako); vimentin (clone Vim 3B; 1.2 lg/ml; Dako); Ki-67 (mouse; clone Ki-S5; 5 lg/ml; Chemicon); and p57/Kip2 (rabbit; 2 lg/ml; c-20; Santa Cruz Biotechnology). Next, samples were incubated with secondary antibodies Alexa Fluor 488 (anti-mouse) and Alexa Fluor 568 (anti-rabbit), both at a concentration of 4 lg/ml (Molecular Probes), stained with 4 0 ,6-diamidino-2-phenylindole (DAPI; 1 lg/ml; Roche), and embedded using Fluoromount G (Soubio). Stained sections were analyzed by fluorescence microscopy (Olympus BX50) and digitally photographed at a 200-fold magnification. As negative controls, the primary antibodies were omitted from the reaction.
Cell Culture of Primary First-Trimester Villous Trophoblasts, Fibroblasts, and EVTs
Primary villous trophoblasts and EVTs of pooled first-trimester placentae (n ¼ 24) between the 7th and 12th wk of gestation were isolated by adapted enzymatic dispersion and Percoll density gradient centrifugation (10%-70%; Pharmacia) using established protocols [19, 26, 31, 32] . Briefly, villous tips were scraped with a scalpel blade and digested two times for 25 min with 0.125% (w/v) trypsin (Gibco) and 12.5 mg/ml DNAse I (Sigma) in 10% (v/v) HBSS-Mg/Ca free (Sigma). After filtering through a 70-lm cell strainer (Greiner Bio-One GmbH), the pooled cell suspensions were poured onto the Percoll gradient and centrifuged. Villous trophoblasts were additionally immune purified using a monoclonal anti-HLA class I antigen antibody, removing residual mesenchymal cells and EVTs (Sigma). Cell preparations of villous trophoblasts and EVTs were cultivated on gelatin-coated (24 h) and fibronectincoated (72 h) dishes, respectively. Cultures were routinely checked by immunofluorescence in chamber slides using cytokeratin 7 (clone OV-TL 12/ 30; 8.3 lg/ml; Dako) and vimentin (clone Vim 3B4; 1.2 lg/ml; Dako) antibodies to detect trophoblasts and stromal cells, respectively. Purities of villous trophoblasts and EVTs were 95%-97% and 93%-95%, respectively. First-trimester villous fibroblasts were isolated from the gradients of trypsinized placental material (between 25% and 35% Percoll) and passaged twice in DMEM supplemented with 10% (v/v) FCS as described previously [19] . Villous fibroblasts were characterized by vimentin immunocytochemistry (100%), and a contamination with trophoblasts was excluded by cytokeratin 7 staining.
Gene Silencing of AKT1, AKT2, and AKT3
Stable knockdowns of the three PKB/Akt isoforms in SGHPL-5 cells were generated by transduction with the miRNA-adapted retroviral vector LMP (Open Biosystems) as previously described [26, 28] . Briefly, short-hairpin miRNAs against human Akt1, Akt2, and Akt3 obtained in pSM2 vector (Open Biosystems) were subcloned into the LMP vector with XhoI and EcoRI (Invitrogen) restriction enzymes. To produce murine stem cell virus particles, HEK293FT cells (Invitrogen) were transiently cotransfected with a vector containing the viral proteins (gag, pol), a vector containing VSV-g, and plasmids harboring either nontargeting shRNAmir (control) or shRNAmirAkt1, shRNAmirAkt2, or shRNAmirAkt3. Lipofectamine 2000 (Invitrogen) reagent was used for transfection. Forty-eight hours after transfection, viral supernatants were collected, supplemented with 8 lg/ml Polybrene (Sigma), and used to infect SGHPL-5 cells. Stable integrants/cell pools were selected with puromycin (5 ng/ml) during a period of 2 wk. To determine the efficiency of the particular knockdown, shRNAmir cells were seeded in 12-well plates at a density of 3 3 10 5 cells per well. After an additional 24 h, protein lysates were prepared and analyzed by Western blotting using AKT isoform-specific antibodies. For growth factor-dependent activation of AKT, cells were serum starved overnight and subsequently incubated in the absence or presence of 5 ng/ml EGF for 20 min.
Proliferation Assay
Proliferation of shRNAmir-transfected SGHPL-5 cell pools was determined by counting cumulative cell numbers. 5 3 10 4 cells per 12-well plate were seeded in triplicates in the absence or presence of 5 ng/ml EGF (Sigma). Cell numbers were measured after 24, 48, 72, and 96 h using a multichannel electronic cell counter (CASY-I Schärfe Systems).
Migration Assay
Migration assays with the different shRNAmir SGHPL-5 cell pools were performed using non-coated (Costar) 8-lm pore transwells as recently described [30] . Briefly, 500 ll of DMEM/Ham F-12 medium supplemented with 10% (v/v) FCS and 0.05 mg/ml gentamicin were added to the lower chamber. A total of 50 000 cells were seeded in the upper chamber using the same medium (200 ll). Upon growth factor stimulation 5 ng/ml EGF was added to both chambers. After 24 h cells were washed three times with PBS, HASLINGER ET AL.
fixed for 10 min in ice-cold methanol, again washed three times with PBS and subsequently incubated with DAPI (1 lg/ml; Roche) for 10 min. Nonmigrated cells on the upper side of the inserts were removed by a cotton swap. Membranes were cut out with a scalpel blade, placed on glass slides, and embedded with Fluoromount G. Nuclei of cells on the underside of membranes were counted under fluorescence using CellP software (Olympus Soft Imaging Solutions). Five nonoverlapping pictures of each membrane representing approximately 40%-50% of the overall surface were taken (40-fold magnification) and digitally analyzed.
Preparation of Protein Lysates and Western Blot Analyses
Protein extraction and Western blot analyses of cell pools stably expressing shRNAmir against AKT1, AKT2, or AKT3 were performed using standard protocols as recently described [20, 26] . Equal amounts of protein lysate (20 lg) were separated on 10% SDS/polyacryl amide (PAA) gels and transferred onto methanol-activated polyvinyldene difluoride (PVDF) membranes (Amersham) in a buffer containing 25 mM Tris-HCl, pH 8.3; 0.5% (w/v) SDS; 192 mM glycine; and 20% (v/v) methanol. Subsequently, PVDF membranes were blocked with 5% (w/v) nonfat dry milk/Tris-buffered saline-Tween 20 (TBS-T) for 60 min at room temperature to eliminate unspecific binding and incubated overnight with primary antibodies in 0.5% (w/v) nonfat dry milk/TBS-T at 48C. Protein loading was controlled by staining with Ponceau S solution (0.1% [w/v] Ponceau S, 5% [v/v] acetic acid in ddH 2 O). After blocking in 5% (w/v) milk/ PBS-Tween (0.05%), membranes were incubated with different primary antibodies. For detection of AKT isoforms, rabbit anti-human antibodies against AKT1 (1:1000; Cell Signaling Technology), AKT2 (1:500; Cell Signaling Technology), and AKT3 (0.09 lg/ml; Sigma) were used. Phosphorylated forms of AKT1 were detected with rabbit anti-human antibodies against p-AKT Ser473 (1:500; Cell Signaling Technology) and p-AKT Thr308 (1:500; Cell Signaling Technology), also detecting the equivalent amino acid residues of AKT2 (Ser474, Thr309) and AKT3 (Ser472, Thr305). Phosphorylated and total forms of mammalian target of rapamycin (mTOR) were analyzed using a rabbit antibody against Ser2448 (1:1000; Cell Signaling Technology) and a mouse monoclonal antibody (L27D4; 1:1000; Cell Signaling Technology), respectively; p-p38 MAPK (Thr180/Tyr182), p-p42/p44 ERK (Thr202/ Tyr204), and p-GSK-3a/b (Ser21/9) were detected using rabbit polyclonal antibodies (1:1000; Cell Signaling Technology). Horseradish peroxidaseconjugated goat anti-rabbit or goat anti-mouse immunoglobulin G (1:50 000; Amersham Biosciences) antibodies were used as secondary reagents. To control for equal loading, the respective blots were stripped and reincubated with rabbit anti-human GAPDH (1:5000; Cell Signaling Technology) or mouse anti-human a-tubulin (1:5000; Calbiochem) antibodies. Horseradish peroxidase signals were detected by enhanced chemiluminescence substrate (ECL Plus Western Blotting Detection System; GE Healthcare) and digitally visualized using a gel documentation system (Alpha Innotech). Quantification of bands was performed using AlphaView software (Alpha Innotech).
Apoptosis Assay
To determine apoptosis, cells were seeded in 24 wells at a density of 1.5 3 10 5 cells per well. After 24 h of cultivation under standard culture conditions, apoptosis was induced by adding 1 lM camptothecin (MP Biomedicals Europe) for 18 h. Controls were treated with dimethyl sulfoxide only. Subsequently, cell lysates were prepared as described above. To measure apoptosis, Western blot analyses for caspase 3 were performed as mentioned above. Pro (35 kDa) and active forms of caspase 3 at 17 kDa and 19 kDa were detected using a rabbit polyclonal antibody direct against caspase 3 (1:1000; Cell Signaling Technology). Concentration of camptothecin (0.1, 1, and 10 lM) and length of treatment (0, 6, 12, 18, and 24 h) were optimized in a pilot experiment. Whereas cell numbers started to decrease at 12 h, active caspase 3 could not be detected before 18 h of treatment with 1 lM camptothecin (data not shown).
Statistical Analyses
Statistical analyses were performed with Student paired t-test using SPSS 14 (SPSS Inc.). Gaussian distribution and equality of variances were examined with Kolmogorov-Smirnov test and Levene test, respectively. A P value of ,0.05 was considered statistically significant.
RESULTS
Expression Pattern of AKT Isoforms in Trophoblasts
Descriptive studies were performed to analyze expression and localization of AKT family members in placental tissues, primary trophoblasts, and EVT cell lines (Fig. 1) . Western blot analyses revealed abundant expression of AKT1, AKT2, and AKT3 in first-trimester villous cytotrophoblasts (vCTBs), EVTs, and villous fibroblasts as well as in HTR-8/SVneo cells, JEG-3 cells, and extravillous, trophoblastlike SGHPL-5 cells (Fig. 1A) . Accordingly, AKT isoforms were also detected in the different trophoblast subtypes of first-trimester placental tissues using immunofluorescence (Fig. 1B) . AKT1, AKT2, and AKT3 were expressed in vCTBs; in proliferative, Ki-67-positive cell column trophoblasts; and in differentiated, Kip2/ p57-expressing EVTs, but only AKT3 was detectable in the syncytium. AKT1 was localized in the cytoplasm but also in some nuclei of vCTBs and EVTs, whereas AKT2 largely displayed cytosolic expression and decreased during EVT differentiation. In contrast, AKT3 was mainly detected in the nuclei of trophoblasts. In agreement with the histologic analyses of placental tissues, immunofluorescence of SGHPL-5 cells revealed AKT1 expression both in nuclei and cytoplasm, whereas AKT2 and AKT3 were predominantly expressed in the cytoplasm and in nuclei, respectively (Fig. 1C) .
Gene Silencing of AKT Isoforms in SGHPL-5 Cells
To analyze the functional role of individual AKT isoforms in trophoblast cell motility, gene silencing of AKT1, AKT2, or AKT3 was performed. Constitutive downregulation in trophoblastic SGHPL-5 cells was achieved upon retroviral transduction of plasmids expressing shRNAmir against the different AKT isoforms and subsequent puromycin selection. Western blot analyses of the three stable cell pools revealed considerable reduction of AKT1, AKT2, and AKT3 expression, respectively, compared with the shRNAmir control ( Fig. 2A) . Loss of each of the AKT proteins was not compensated by upregulation of the other isoforms. Densitometrical scanning indicated that levels of AKT1, AKT2, and AKT3 significantly decreased to 16%, 8%, and 11%, respectively, compared with the expression in control shRNAmir cells (100%; Fig. 2B ).
Gene Silencing of AKT1 and AKT3 Affects Basal and EGFStimulated Trophoblast Migration
To investigate the role of AKT isoforms in trophoblast migration, SGHPL-5 cell pools harboring shRNAmir against AKT1, AKT2, or AKT3 were analyzed in uncoated transwell assays in the absence of presence of EGF (Fig. 3) . Similar to previous data using SGHPL-5 cells [19] , EGF stimulated motility of the shRNAmir cell pools. Quantification revealed that gene silencing of AKT1 and AKT3 but not of AKT2 reduced basal migration. Compared with EGF-stimulated control shRNAmir, growth factor-dependent motility decreased to 54% and 48% in AKT1 and AKT3 shRNAmir cell pools, respectively. Again, downregulation of AKT2 did not affect EGF-induced cell migration. Decreased migration of AKT1 and AKT3 shRNAmir cells cannot be explained by changes in cell adhesion, because plating efficiency on plastics was not significantly different between gene-silenced pools and controls (data not shown).
Gene Silencing of AKT Isoforms Does Not Affect Trophoblast Cell Proliferation
Cell proliferation was analyzed in the shRNAmir-expressing cell pools by counting cumulative cell numbers. Neither in untreated nor in EGF-treated cells could statistically significant changes be observed between control shRNAmir and AKT1, AKT2, or AKT3 shRNAmir, respectively (Fig. 4) .
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Downregulation of Individual AKT Proteins Does Not Alter Sensibility to Camptothecin-Induced Apoptosis
To investigate whether loss of each of the AKT isoforms might provoke changes in apoptosis, control shRNAmir and shRNAmir-AKT1, shRNAmir-AKT2, or shRNAmir-AKT3 cell pools were incubated in the presence of the topoisomerase I inhibitor camptothecin and analyzed by Western blotting using antibodies against executioner caspase 3 (Fig. 5) . Western blot analyses revealed production of active forms of caspase 3 (17 and 19 kDa) after 18 h of camptothecin treatment (Fig. 5A) . However, densitometrical scanning of blots indicated that gene silencing of each of the AKT isoforms, respectively, was not sufficient to sensitize cultures to camptothecin-induced apoptosis (Fig. 5B) . Treatment with FasL provoked activation of caspase 3 in Jurkat cells but not in SGHPL-5 cells, suggesting that the extrinsic, apoptotic pathway cannot be effectively stimulated in the latter (data not shown).
Gene Silencing of AKT1 or AKT3 Reduces EGF-Stimulated Phosphorylation of AKT
EGF-dependent activation of AKT was analyzed in the different shRNAmir SHGPL-5 cell pools (Fig. 6) . Western blot analyses suggested that gene silencing of AKT1 or AKT3, but not of AKT2, provoked downregulation of EGF-induced phosphorylation of total AKT at Ser473 and Thr308, respectively (Fig. 6A) . Quantification of Western blots revealed that compared with EGF-stimulated shRNAmir controls, phosphorylation of AKT at Ser473 was reduced to 45% and 37% in growth factor-treated shRNAmir-AKT1 and shRNAmir-AKT3 cell pools, respectively (Fig. 6B) . Similarly, p-AKT Thr308 decreased to 57% and 26% in EGF-treated AKT1 and AKT3 gene-silenced cell pools each. In AKT2 shRNAmir cells, however, only AKT phosphorylation at Ser473 sites was weakly affected.
Gene Silencing of AKT1 or AKT3 Decreases EGF-Induced Phosphorylation of mTORC1
AKT-dependent phosphorylation of mTOR is thought to play a critical role in trophoblast cell migration [17] . To investigate whether gene silencing of AKT isoforms affects mTORC1 activation, its phosphorylation at Ser2448 was analyzed by Western blot analyses (Fig. 7A) . Compared with shRNAmir controls, weaker signals of activated mTORC1 were detected in EGF-treated AKT1 and AKT3 gene-silenced SGHPL-5 cells. Quantification of blots suggested that pmTORC1 decreased to 54.6% and 55.1% in AKT1 and AKT3 shRNAmir-treated cultures, respectively, whereas gene silencing of AKT2 was not effective (Fig. 7B) . Activation of other signaling kinases, such as p38 MAPK, ERK, or GSK-3a/b, likely contributing to EGF-induced trophoblast migration, was not affected upon gene silencing of AKT isoforms (Supplemental Fig. S1 , available online at www.biolreprod.org). The different SGHPL-5 cell pools constitutively expressing control shRNAmir or shRNAmir against AKT1, AKT2, or AKT3 were stimulated with EGF and subjected to migration assays as described above. Bars represent mean values 6 SD for each of four independent control and AKT1, AKT2, and AKT3 shRNAmir-expressing cell pools analyzed in duplicates. *P , 0.05; ns indicates not significant compared with control shRNAmir.
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DISCUSSION
Signaling through activation of the PI3K/AKT plays a critical role in trophoblast migration and invasion [13, 33] . Numerous growth factors and hormones produced at the fetalmaternal interface, for example, IGF-II, HGF, EGF, heparinbinding EGF (HB-EGF), Wnts, or human chorionic gonadotropin (hCG), provoke AKT activation and AKT-dependent motility [16] [17] [18] [19] 34] . Along those lines, chemical inhibition of PI3K/AKT negatively affected basal as well as growth factorinduced trophoblast migration and invasion [18] [19] [20] . Blocking PI3K/AKT signaling may also represent a physiological mechanism to attenuate migration of trophoblasts; decidual endostatin, which is cleaved from its precursor collagen XVIII by trophoblast-derived MMPs, was recently shown to reduce trophoblast migration by impairing growth factor-stimulated AKT activation [35, 36] .
Whereas accumulating evidence suggests that PI3K/AKT signaling is crucially involved in trophoblast cell motility, distribution of the three AKT isoforms in the human placenta and their subcellular localization in trophoblasts have not been unraveled. Moreover, previous studies in trophoblasts only used chemical inhibitors to block total PI3K/AKT signaling, which can trigger apoptosis besides interfering with cell migration [37] .
AKT1, AKT2, and AKT3 may fulfill differential functions in trophoblasts. Indeed, AKT isoforms were shown to exhibit distinct roles in biological processes, such as glucose metabolism, activation of macrophages or apoptosis, and axon growth of neurons [38] [39] [40] . Hence, to gain more insight into the role of the different AKT proteins in trophoblasts, in the present study we analyzed placental expression patterns of AKT1, AKT2, and AKT3 in first-trimester placental tissues and studied their properties in trophoblast proliferation and motility using SGHPL-5 cells as a model system.
Immunofluorescence of first-trimester placenta indicated expression of AKT isoforms in all subtypes of cytotrophoblasts, regardless of the proliferative capacity. Because AKT1, AKT2, and AKT3 were detectable in proliferative vCTBs, cell columns, and differentiated EVTs, a role in trophoblast proliferation and migration could be suggested. Although AKT1 and AKT2 are considered to be ubiquitously expressed in tissues, AKT3 is expressed at higher levels in heart, brain, kidney, and placenta [41] . Abundance of AKT3 in total placental tissues might be largely due to its strong expression in trophoblasts, producing higher levels than villous stromal cells. Whereas AKT1 and AKT2 were absent from syncytiotrophoblasts in first-trimester placental sections, AKT3 was the only isoform detectable in the syncytium. AKT3 also accumulated during in vitro differentiation of isolated term villous trophoblasts, suggesting a role in syncytialization (Haslinger and Knöfler, unpublished observation). Discovering a possible function of AKT3 in trophoblast cell fusion, however, requires further molecular analyses. Also, differences in subcellular localization of AKT isoforms in trophoblasts were noticed. Extravillous trophoblasts and villous cytotrophoblasts in situ, as well as SGHPL-5 cells in vitro displayed nuclear and cytoplasmic expression of AKT3 and AKT2, respectively, whereas AKT1 was predominantly expressed in the cytoplasm and some nuclei. These data fit with previous observations localizing AKT1, AKT2, and AKT3 to the cytoplasm, cytoplasm/mitochondria, and nucleus, respectively, in diverse cancer and noncancer epithelial cell lines, although localization may vary between different cell types [42, 43] . Interestingly, downregulation of one AKT isoform did not influence localization and expression of the other AKT proteins, suggesting distinct modes of activation [42] . In agreement with that, silencing of each of the AKT proteins in SGHPL-5 cells also did not affect expression of the other isoforms in Western blot analyses.
Accumulating evidence suggests that the different AKT proteins play specific roles in physiological and cancer cell migration [23, 40] . For example dominant-positive AKT1 or overexpression of AKT1 or AKT2 increased in vitro invasion and the metastatic potential of diverse cancer cells [44, 45] . In breast tumor cell lines, however, AKT1 inhibited cell motility, whereas activation of AKT2 promoted migration and invasion [46] [47] [48] . In these models AKT1 negatively affected expression of proinvasive genes, such as NFAT, TSC-2, or ERK, whereas AKT2 promoted upregulation of b1 integrin [49] . In support of this, AKT2 and AKT3 were shown to be expressed at higher levels in ovarian carcinomas [50, 51] . In contrast, AKT1 was shown to promote motility in nontransformed fibroblast cells, whereas AKT2 downregulated the process by inhibiting the activation of promigratory Rac and Pak1 [25] . Hence, isoformspecific roles of AKT are largely dependent on the cellular and tissue context, but they are also influenced by their subcellular localization, which may vary upon growth factor stimulation [42, 43, 52] . Distinct localization of AKT isoforms in cytotrophoblasts also prompted us to evaluate possible 
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functional differences between AKT1, AKT2, and AKT3. Indeed, shRNAmir-mediated silencing of AKT1 or AKT3 diminished basal and EGF-induced SGHPL-5 cell migration, whereas downregulation of AKT2 did not affect migration through uncoated transwells. Therefore, we conclude that AKT1 and AKT3 play critical but redundant roles in trophoblast cell migration, whereas AKT2 may not be involved in this particular process. AKT2-dependent migration could be predominantly a feature of cancers cells, whereas different analyses suggest that AKT2 activity of physiological cells could be largely associated with metabolic signaling and cell survival [40, 42] . Furthermore, the data suggest that autocrine factors produced by invasive trophoblasts act through the PI3K/AKT pathway, because basal invasion decreased in AKT1 and AKT3 knockdown cells. Whereas EGF and HGF are predominantly expressed in the decidua, trophoblastderived proteins, such as HB-EGF, hCG, Wnt ligands, and IFG-II, could be involved in autocrine AKT signaling [33] .
Overexpression of AKT provides a growth advantage to tumor cells by suppressing apoptosis. However, AKT proteins also play a direct role in proliferation, because AKT isoforms were shown to differentially regulate cell cycle progression in nontransformed cells [53, 54] . Here, gene silencing of neither AKT1, AKT2, nor AKT3 affected basal, or EGF-induced cell growth of SGHPL-5 cells, suggesting that none of the AKT isoforms are involved in trophoblast proliferation. In this context, however, it is noteworthy that AKT2 was strongly expressed in cell columns but decreased during EVT formation. Further experiments using siRNA-mediated downregulation of AKT2 in first-trimester villous explant cultures or primary cells might be required to ascertain whether the particular isoform plays any role in trophoblast proliferation.
On the other hand, IGF-I-dependent and IGF-II-dependent growth of villous cytotrophoblasts was not altered upon chemical inhibition of total PI3K/AKT signaling [55] . Hence, it is likely that growth factor-dependent rescue from apoptosis and promotion of cell migration are the predominant functions of the AKT pathway in trophoblasts [33, 55] . Similar to the proliferation data, basal and camptothecin-induced apoptosis did not change upon gene silencing of AKT1, AKT2, or AKT3, suggesting redundant functions of AKT isoforms. Expression of one isoform might be sufficient to inhibit programmed cell death. Indeed, a previous study using cancer cells suggested that simultaneous knockdown of all three FIG. 7. Epidermal growth factor-induced phosphorylation of mTORC1 in control shRNAmir and in AKT1, AKT2, or AKT3 shRNAmir cells. Growth factor stimulation, Western blot analyses using antibodies against phosphorylated and total mTOR, and densitometrical quantification of signals were performed as described in Materials and Methods. A) Western blots showing expression of p-mTORC1 Ser2448 and total mTOR in the different AKT knockdown cell pools. GAPDH was used as a loading control. Representative examples are shown. B) Densitometrical quantification of p-mTORC1 Ser2448 in EGFstimulated controls and in AKT1, AKT2, and AKT3 shRNAmir cells. Bar graphs show mean values 6 SD each for n ¼ 3 different gene-silenced SGHPL-5 cell pools and controls (arbitrarily set at 100%). *P , 0.05; ns indicates not significant compared with control shRNAmir.
isoforms of the kinase was necessary to affect cell proliferation and survival [56] .
IGF-II-dependent trophoblast cell migration involves activation of AKT by phosphoinositide-dependent kinase 1 (PDK1) at Thr308 of the catalytic domain as well as by the mTORC2 complex phosphorylating Ser473 within the Cterminal region of the protein [35] . Similarly, previous results together with the data shown here suggest that EGF induces trophoblast motility by stimulating AKT phosphorylation at Thr308 and Ser473 [57, 58] . Gene silencing of isoforms indicated that both AKT1 and AKT3 are activated through phosphorylation at these amino acid residues. Knockdown of AKT2 only slightly decreased phosphorylation at p-Ser473 but did not affect p-Thr308, suggesting that EGF may not effectively stimulate AKT2. Indeed, EGF-dependent activation of AKT isoforms varies considerably, even within different cell lines of the same cell type [59] . Along those lines, EGF treatment did not provoke AKT2 phosphorylation in several cell lines of esophageal cancer [59] .
Numerous growth factors are thought to stimulate trophoblast motility through activation of PI3K/AKT signaling [13, 33] , but only a few direct targets of AKT, such as FOS-like 1 [60] or mTORC1, have been identified and functionally characterized in trophoblasts. Chemical inhibition and siRNA-mediated downregulation of mTORC1 indicated that the kinase plays a role in human trophoblast migration [17, 61] . Indeed, gene silencing of AKT isoforms performed here indicated that EGF-stimulated AKT1 and AKT3 activate mTORC1 through phosphorylation at its critical residue Ser2448, providing further evidence for a critical role of PI3K/AKT/mTORC1 signaling in trophoblast motility. Besides AKT signaling, activation of ERK and p38 MAPK was shown to be critical for EGF-dependent trophoblast motility [57] . In agreement with this previous study, EGFinduced phosphorylation of ERK, p38 MAPK, and GSK-3b was noticed in SGHPL-5 cells. Silencing of AKT isoforms, however, did not affect EGF-stimulated activation of these pathways, suggesting independent roles of PI3K/AKT and MAPK signaling in trophoblast cell migration.
Although unique functions of the different AKT proteins have been described in other cellular systems [24, 25] , the present investigation suggests redundant roles of AKT1 and AKT3 in trophoblast migration. Hence, further studies are required to delineate putative AKT isoform-specific differences with respect to localization, growth factor-dependent activation, and induction of downstream targets in trophoblasts.
